The Vanguard Group 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD | The Vanguard Group | 28,492,486 9.720% | 1,954,115 (+7.36%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | The Vanguard Group | 26,538,371 9.450% | 893,187 (+3.48%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | The Vanguard Group | 25,645,184 9.200% | 1,799,751 (+7.55%) | Filing |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | The Vanguard Group | 23,845,433 9.150% | 86,273 (+0.36%) | Filing |
| 2020-02-12 07:57 am Purchase | 2019-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | The Vanguard Group | 23,759,160 9.320% | 6,587,163 (+38.36%) | Filing |